Impact on DMEPOS Providers: The Biden Administration Announces New Actions to Lessen the Burden of Medical Debt and Increase Consumer Protection

Published in Government Relations on April 19, 2022

The White House is seeking to help lessen Americans' medical debt burden, Vice President Kamala Harris announced Monday, April 11, 2022. In its latest effort to help people deal with increased costs amid skyrocketing inflation, and with emphasis on collection practices by providers and third-party collection agencies, the White House laid out a four-point plan to help protect consumers. Officials from several federal agencies spoke of the problems of medical debt, which plagues about one-third of American adults and is the largest source of debt in collections. Being behind in bills also prompts some people to avoid seeking additional health care and can affect consumers' ability to buy homes or start small businesses. VGM has been contacted by several DMEPOS suppliers with several questions and concerns relative to their ability to waive patient co-payments in conjunction with the White House efforts to ease medical debt. VGM’s vice president of regulatory affairs Mark Higley and vice president of payer relations Craig Douglas presents a summary of the new actions, the potential affect – along with certain perils – to DMEPOS companies concerning the topics covered in this newly released memo, and offers a comprehensive procedural outline to mitigate potential risks with federal, state and private payers. Read More Here!

From Our Experts

The PHE Will End May 11 thumbnail The PHE Will End May 11 President Biden has announced that the COVID-19 Public Health Emergency (PHE) will officially end on May 11, 2023. Tom Powers Visit Washington D.C. thumbnail Tom Powers Visit Washington D.C. With the start of the 118th Congress and all members of Congress returning to D.C., VGM Government Relations' Tom Powers headed to Capitol Hill. OIG Recommends 'High/Low Reward' Strategy on Intermittent Catheters thumbnail OIG Recommends 'High/Low Reward' Strategy on Intermittent Catheters In this episode of Industry Matters, Alan Morris, Director of Research and Strategy for VGM Government Relations, and John Gallagher, VP of VGM Government Relations, talk with Brian Leitten from Leitten Consulting, about a new study, "OIG Recommends 'High Risk/Low Reward' Strategy on Intermittent Catheters." The study looks at concerns and costs associated with reducing access to urinary catheters. Additional HCPCS Codes Added to F2F/WOPD Required List thumbnail Additional HCPCS Codes Added to F2F/WOPD Required List On Jan. 14, 2023, CMS released a public notice CMS-6088-N, adding 10 more HCPCS codes to the F2F/WOPD Required List. Ronda Vlog: Recent Updates to the New Oxygen Policy thumbnail Ronda Vlog: Recent Updates to the New Oxygen Policy Listen below as Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement gives the latest update on the new oxygen policy. Republicans Announce New Members on Key Committees thumbnail Republicans Announce New Members on Key Committees On Wednesday, Jan. 11, 2023, the United States House Republican Select Committee met to announce the new Republican members appointed to various committees in the House. For the DME industry, there are three key committees of justification to work with. PHE Renewed for Another 90 Days Pushing it to April 2023 thumbnail PHE Renewed for Another 90 Days Pushing it to April 2023 On Wednesday, Jan. 11, 2023, HHS Secretary Xavier Becerra announced an extension of the COVID-19 Public Health Emergency (PHE). This extension will take us to April 2023. Be sure to read how this will effect the industry. President Biden Signs Omnibus Bill Two Days Before The New Year thumbnail President Biden Signs Omnibus Bill Two Days Before The New Year Yesterday, Dec. 29, 2023, President Biden signed the end-of-year omnibus bill. Within this bill, there is a language for the DMEPOS industry.